Cardinal profit up on generic drugs, medical products
Feb 5 (Reuters) - Drug wholesaler Cardinal Health Inc said on Tuesday that quarterly earnings had risen 16 percent, driven by increased sales of generic medicines and medical products such as surgical gowns and instruments.
Net earnings in the second quarter ended Dec. 31 rose to $303 million, or 88 cents a share, from $262 million, or 75 cents a share, a year earlier.
Earnings from continuing operations excluding one-time items rose to 93 cents a share from 81 cents.
- Total CEO de Margerie killed in Moscow as jet hits snow plow |
- Sweden gets two new sightings, as hunt for undersea intruder goes on
- Pistorius starts five-year term for killing Reeva Steenkamp
- U.S. to funnel travelers from Ebola-hit region through five airports
- Ebola crisis turns a corner as U.S. issues new treatment protocols